Surveillance for adult and pediatric RSV-associated hospitalizations
The Oregon Emerging Infections Program (EIP) has conducted surveillance for adult Respiratory Syncytial Virus (RSV) hospitalizations in collaboration with the Centers for Disease Control and Prevention (CDC) RSV-Associated Hospitalization Surveillance Network (RSV-NET) since 2016. Surveillance for pediatric RSV-associated hospitalizations was added in 2018.
The objectives for the surveillance are to estimate age, race and ethnicity of RSV hospitalization rates in Oregon. In addition, surveillance is used to describe the following: temporal trends of laboratory-confirmed RSV hospitalizations, characteristics among persons hospitalized and clinical features of RSV disease.
Case definition: Cases are defined as laboratory-confirmed RSV hospitalizations among residents of the EIP surveillance area (Clackamas, Multnomah and Washington counties) who test positive for RSV within 14 days before admission or 3 days after admission.
Hospital and mortality data